Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 1/2022

01-01-2022 | Chronic Lymphocytic Leukemia | Letter to the Editor

Intracranial hemorrhage as presentation of chronic lymphocytic leukemia successfully treated with ibrutinib

Authors: Fernando Martín-Moro, Mónica García-Cosío, Juan Marquet-Palomanes, María López-Gutiérrez, Héctor Pian-Arias, Francisco Javier López-Jiménez

Published in: Annals of Hematology | Issue 1/2022

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Otani R, Uzuka T, Matsuda H, Higuchi F, Kim P, Ueki K (2019) Brain invasion by chronic lymphocytic leukemia. Neuropathology 39:54–57CrossRef
2.
Cramer SC, Glaspy JA, Efird JT, Louis DN (1996) Chronic lymphocytic leukemia and the central nervous system: a clinical and pathological study. Neurology 46:19–25CrossRef
3.
Timmers NKLM, de Maar JS, van Kruijsdijk RCM, Klein SK (2018) Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature. Ann Hematol 97:1627–1632CrossRef
4.
Hallek M (2019) Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. Am J Hematol 94:1266–1287CrossRef
5.
Wanquet A, Birsen R, Lemal R, Hunault M, Leblond V, Aurran-Schleinitz T (2016) Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia. Blood 127:2356–2358CrossRef
Metadata
Title
Intracranial hemorrhage as presentation of chronic lymphocytic leukemia successfully treated with ibrutinib
Authors
Fernando Martín-Moro
Mónica García-Cosío
Juan Marquet-Palomanes
María López-Gutiérrez
Héctor Pian-Arias
Francisco Javier López-Jiménez
Publication date
01-01-2022
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 1/2022
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-021-04393-3

Other articles of this Issue 1/2022

Annals of Hematology 1/2022 Go to the issue

Letter to the Editor

Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study

Original Article

miRNA profile and disease severity in patients with sickle cell anemia

Original Article

Favorable overall survival with imetelstat in relapsed/refractory myelofibrosis patients compared with real-world data

Letter to the Editor

Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies

Letter to the Editor

Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia

Original Article

Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits